Tapewire

NYSE · USD

ABT

ABBOTT LABORATORIES

Export transactions ↓
Tapewire entity
2314
SEC CIK
0000001800
Parsed reports
2,562

Last 12 months

Inside the activity.

6 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202610
Feb 202620
Mar 202606
Apr 202620
May 202610
Jun 202600
Jul 202600
Aug 202603
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 21, 2008 Filed Jul 23, 2008 21:16 UTC
WHITE MILES DDirector · Chairman and CEO
Exercise / conversionCommon shares without par value 224,097 $44.60 $9,994,726.20
Disclosure

SEC source: 0001104659-08-047208 · a4.xml · nonDerivative · entry 2

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,361,945

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 21, 2008 Filed Jul 23, 2008 21:16 UTC
WHITE MILES DDirector · Chairman and CEO
Exercise / conversionCommon shares without par value 10,128 $42.50 $430,417.72
Disclosure

SEC source: 0001104659-08-047208 · a4.xml · nonDerivative · entry 1

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,137,848

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 21, 2008 Filed Jul 23, 2008 21:21 UTC
FREYMAN THOMAS CExecutive Vice President
Exercise / conversionCommon shares without par value · Derivative 27,848 $0.00 Strike: $53.19 $0.00
Disclosure

SEC source: 0001104659-08-047211 · a4.xml · derivative · entry 7

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 27,848 shares

Expires 2009-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 21, 2008 Filed Jul 23, 2008 21:21 UTC
FREYMAN THOMAS CExecutive Vice President
Tax withholdingCommon shares without par value 26,563 $57.58 $1,529,497.54
Disclosure

SEC source: 0001104659-08-047211 · a4.xml · nonDerivative · entry 2

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,426

Read SEC document
July 21, 2008 Filed Jul 23, 2008 21:21 UTC
FREYMAN THOMAS CExecutive Vice President
Exercise / conversionCommon shares without par value 27,848 $53.19 $1,481,235.12
Disclosure

SEC source: 0001104659-08-047211 · a4.xml · nonDerivative · entry 1

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 15, 2008 Filed Jul 17, 2008 22:32 UTC
Michael Edward L.Executive Vice President
Tax withholdingCommon shares without par value 1,973 $56.22 $110,922.06
Disclosure

SEC source: 0001104659-08-046178 · a4.xml · nonDerivative · entry 1

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,122

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:02 UTC
Mason Heather LSenior Vice President
GrantOption (right to buy) · Derivative 1,185 $0.00 Strike: $57.37 $0.00
Disclosure

SEC source: 0001104659-08-045348 · a4.xml · derivative · entry 4

Mason Heather L · CIK 0001432601 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,185

Underlying: Common Shares · 1,185 shares

Expires 2011-02-08

F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:02 UTC
Mason Heather LSenior Vice President
Exercise / conversionOption (right to buy) · Derivative 1,355 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-08-045348 · a4.xml · derivative · entry 3

Mason Heather L · CIK 0001432601 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 1,355 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:02 UTC
Mason Heather LSenior Vice President
Tax withholdingCommon shares without par value 1,185 $57.37 $67,983.45
Disclosure

SEC source: 0001104659-08-045348 · a4.xml · nonDerivative · entry 2

Mason Heather L · CIK 0001432601 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,176

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:02 UTC
Mason Heather LSenior Vice President
Exercise / conversionCommon shares without par value 1,355 $45.45 $61,583.12
Disclosure

SEC source: 0001104659-08-045348 · a4.xml · nonDerivative · entry 1

Mason Heather L · CIK 0001432601 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,361

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Patton Donald V JRSenior Vice President
GrantOption (right to buy) · Derivative 7,431 $0.00 Strike: $57.37 $0.00
Disclosure

SEC source: 0001104659-08-045349 · a4.xml · derivative · entry 5

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,431

Underlying: Common Shares · 7,431 shares

Expires 2011-02-08

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Patton Donald V JRSenior Vice President
Exercise / conversionOption (right to buy) · Derivative 8,451 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-08-045349 · a4.xml · derivative · entry 4

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,297

Underlying: Common Shares · 8,451 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Patton Donald V JRSenior Vice President
Tax withholdingCommon shares without par value 7,431 $57.37 $426,316.47
Disclosure

SEC source: 0001104659-08-045349 · a4.xml · nonDerivative · entry 2

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,561

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Patton Donald V JRSenior Vice President
Exercise / conversionCommon shares without par value 8,451 $45.45 $384,087.81
Disclosure

SEC source: 0001104659-08-045349 · a4.xml · nonDerivative · entry 1

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,992

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Szela Mary TSenior Vice President
GrantOption (right to buy) · Derivative 10,819 $0.00 Strike: $57.37 $0.00
Disclosure

SEC source: 0001104659-08-045350 · a4.xml · derivative · entry 5

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,819

Underlying: Common Shares · 10,819 shares

Expires 2011-02-08

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Szela Mary TSenior Vice President
Exercise / conversionOption (right to buy) · Derivative 12,376 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-08-045350 · a4.xml · derivative · entry 4

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,457

Underlying: Common Shares · 12,376 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Szela Mary TSenior Vice President
Tax withholdingCommon shares without par value 10,819 $57.37 $620,686.03
Disclosure

SEC source: 0001104659-08-045350 · a4.xml · nonDerivative · entry 2

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,329

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Szela Mary TSenior Vice President
Exercise / conversionCommon shares without par value 12,376 $45.45 $562,474.35
Disclosure

SEC source: 0001104659-08-045350 · a4.xml · nonDerivative · entry 1

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Chen Thomas FSenior Vice President
GrantOptions (right to buy) · Derivative 6,386 $0.00 Strike: $57.37 $0.00
Disclosure

SEC source: 0001104659-08-045351 · a4.xml · derivative · entry 7

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,386

Underlying: Common shares · 6,386 shares

Expires 2011-02-08

F3 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Chen Thomas FSenior Vice President
Exercise / conversionOptions (right to buy) · Derivative 7,306 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-08-045351 · a4.xml · derivative · entry 6

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,896

Underlying: Common shares · 7,306 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Chen Thomas FSenior Vice President
Tax withholdingCommon shares without par value 6,386 $57.37 $366,364.82
Disclosure

SEC source: 0001104659-08-045351 · a4.xml · nonDerivative · entry 2

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,796

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:03 UTC
Chen Thomas FSenior Vice President
Exercise / conversionCommon shares without par value 7,306 $45.45 $332,048.93
Disclosure

SEC source: 0001104659-08-045351 · a4.xml · nonDerivative · entry 1

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,182

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Fussell Stephen RSenior Vice President
GrantOptions (right to buy) · Derivative 10,050 $0.00 Strike: $57.37 $0.00
Disclosure

SEC source: 0001104659-08-045352 · a4.xml · derivative · entry 5

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,050

Underlying: Common shares · 10,050 shares

Expires 2011-02-08

F2 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Fussell Stephen RSenior Vice President
Exercise / conversionOptions (right to buy) · Derivative 11,390 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-08-045352 · a4.xml · derivative · entry 4

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,812

Underlying: Common shares · 11,390 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Fussell Stephen RSenior Vice President
Tax withholdingCommon shares without par value 10,050 $57.37 $576,568.50
Disclosure

SEC source: 0001104659-08-045352 · a4.xml · nonDerivative · entry 2

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,927

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Fussell Stephen RSenior Vice President
Exercise / conversionCommon shares without par value 11,390 $45.45 $517,661.83
Disclosure

SEC source: 0001104659-08-045352 · a4.xml · nonDerivative · entry 1

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,977

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Landgraf John CSenior Vice President
GrantOption (right to buy) · Derivative 21,549 $0.00 Strike: $57.37 $0.00
Disclosure

SEC source: 0001104659-08-045353 · a4.xml · derivative · entry 7

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,549

Underlying: Common Shares · 21,549 shares

Expires 2011-02-08

F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Landgraf John CSenior Vice President
Exercise / conversionOption (right to buy) · Derivative 24,651 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-08-045353 · a4.xml · derivative · entry 6

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,200

Underlying: Common Shares · 24,651 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Landgraf John CSenior Vice President
Tax withholdingCommon shares without par value 21,549 $57.37 $1,236,266.13
Disclosure

SEC source: 0001104659-08-045353 · a4.xml · nonDerivative · entry 2

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,024

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Landgraf John CSenior Vice President
Exercise / conversionCommon shares without par value 24,651 $45.45 $1,120,358.37
Disclosure

SEC source: 0001104659-08-045353 · a4.xml · nonDerivative · entry 1

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,573

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Schumacher Laura JExecutive Vice President
GrantOption (right to buy) · Derivative 4,120 $0.00 Strike: $57.37 $0.00
Disclosure

SEC source: 0001104659-08-045354 · a4.xml · derivative · entry 5

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,120

Underlying: common shares · 4,120 shares

Expires 2011-02-08

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 4,713 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-08-045354 · a4.xml · derivative · entry 4

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,515

Underlying: common shares · 4,713 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Schumacher Laura JExecutive Vice President
Tax withholdingCommon shares without par value 4,120 $57.37 $236,364.40
Disclosure

SEC source: 0001104659-08-045354 · a4.xml · nonDerivative · entry 2

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,069

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Schumacher Laura JExecutive Vice President
Exercise / conversionCommon shares without par value 4,713 $45.45 $214,200.19
Disclosure

SEC source: 0001104659-08-045354 · a4.xml · nonDerivative · entry 1

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Tyree James LExecutive Vice President
GrantOption (right to buy) · Derivative 13,171 $0.00 Strike: $57.37 $0.00
Disclosure

SEC source: 0001104659-08-045355 · a4.xml · derivative · entry 6

Tyree James L · CIK 0001324991 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,171

Underlying: common shares · 13,171 shares

Expires 2011-02-08

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Tyree James LExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 2,200 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-08-045355 · a4.xml · derivative · entry 5

Tyree James L · CIK 0001324991 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 2,200 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Tyree James LExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 13,074 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-08-045355 · a4.xml · derivative · entry 4

Tyree James L · CIK 0001324991 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,602

Underlying: common shares · 13,074 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Tyree James LExecutive Vice President
Tax withholdingCommon shares without par value 13,171 $57.37 $755,620.27
Disclosure

SEC source: 0001104659-08-045355 · a4.xml · nonDerivative · entry 2

Tyree James L · CIK 0001324991 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,344

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:04 UTC
Tyree James LExecutive Vice President
Exercise / conversionCommon shares without par value 15,274 $45.45 $694,184.97
Disclosure

SEC source: 0001104659-08-045355 · a4.xml · nonDerivative · entry 1

Tyree James L · CIK 0001324991 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,515

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:17 UTC
LINDER GREG WVice President
GrantOption (right to buy) · Derivative 8,156 $0.00 Strike: $57.37 $0.00
Disclosure

SEC source: 0001104659-08-045356 · a4.xml · derivative · entry 5

LINDER GREG W · CIK 0001239128 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,156

Underlying: Common Shares · 8,156 shares

Expires 2011-02-08

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:17 UTC
LINDER GREG WVice President
Exercise / conversionOption (right to buy) · Derivative 9,330 $0.00 Strike: $45.45 $0.00
Disclosure

SEC source: 0001104659-08-045356 · a4.xml · derivative · entry 4

LINDER GREG W · CIK 0001239128 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,200

Underlying: Common Shares · 9,330 shares

Expires 2011-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:17 UTC
LINDER GREG WVice President
Tax withholdingCommon shares without par value 8,156 $57.37 $467,909.72
Disclosure

SEC source: 0001104659-08-045356 · a4.xml · nonDerivative · entry 2

LINDER GREG W · CIK 0001239128 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,610

Read SEC document
July 09, 2008 Filed Jul 11, 2008 22:17 UTC
LINDER GREG WVice President
Exercise / conversionCommon shares without par value 9,330 $45.45 $424,037.30
Disclosure

SEC source: 0001104659-08-045356 · a4.xml · nonDerivative · entry 1

LINDER GREG W · CIK 0001239128 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,766

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2008 Filed Jun 30, 2008 22:34 UTC
Szela Mary TSenior Vice President
SaleCommon shares without par value 600 $52.91 $31,746.00
Disclosure

SEC source: 0001104659-08-043192 · a4.xml · nonDerivative · entry 3

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,772

Read SEC document
June 30, 2008 Filed Jun 30, 2008 22:34 UTC
Szela Mary TSenior Vice President
SaleCommon shares without par value 1,569 $52.90 $83,000.10
Disclosure

SEC source: 0001104659-08-043192 · a4.xml · nonDerivative · entry 2

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,372

Read SEC document
June 30, 2008 Filed Jun 30, 2008 22:34 UTC
Szela Mary TSenior Vice President
SaleCommon shares without par value 400 $52.92 $21,168.00
Disclosure

SEC source: 0001104659-08-043192 · a4.xml · nonDerivative · entry 1

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,941

Read SEC document
June 30, 2008 Filed Jul 2, 2008 23:45 UTC GrantStock Equivalent Units · Derivative 453 $52.97 Strike: $0.00 $23,995.41
Disclosure

SEC source: 0001104659-08-043859 · a4.xml · derivative · entry 1

DALEY WILLIAM M · CIK 0001183865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,675

Underlying: Common shares · 453 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2008 Filed Jul 2, 2008 23:46 UTC GrantStock equivalent units · Derivative 481 $52.97 Strike: $0.00 $25,478.57
Disclosure

SEC source: 0001104659-08-043860 · a4.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,216

Underlying: Common Shares · 481 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2008 Filed Jul 2, 2008 23:50 UTC GrantStock equivalent units · Derivative 481 $52.97 Strike: $0.00 $25,478.57
Disclosure

SEC source: 0001104659-08-043861 · a4.xml · derivative · entry 1

TILTON GLENN F · CIK 0001194624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,216

Underlying: Common shares · 481 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2008 Filed Jul 2, 2008 23:51 UTC GrantStock Equivalent Units · Derivative 538 $52.97 Strike: $0.00 $28,497.86
Disclosure

SEC source: 0001104659-08-043862 · a4.xml · derivative · entry 1

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,021

Underlying: Common shares · 538 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.